Pursuant to regulation 47 of SEBI (LODR) regulations, 2015 we are enclosing herewith a copy of newspaper clipping of the extract of Audited Financial Results for the quarter and year ended ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
National Peroxide Ltd has published its audited financial results for the quarter and full year ended March 31, 2025 in Business Standard (English) and Mumbai Lakshadweep (Marathi) on May 7, 2025, as required under SEBI LODR Regulations. For FY25, total revenue from operations stood at ₹28,687.40 lakhs, while the company slipped into a net loss after tax of ₹224.64 lakhs against a profit in the prior year. In Q4 FY25 alone, revenue declined to ₹7,370.44 lakhs (vs ₹8,803.22 lakhs in Q4 FY24) and the company reported a net loss after tax of ₹649.01 lakhs, versus a profit of ₹307.18 lakhs a year ago. Basic and diluted EPS turned negative at ₹(11.29) for Q4 and ₹(3.91) for the full year, compared to ₹5.35 in Q4 FY24. The results were approved by the Board on May 6, 2025, after Audit Committee review on May 5, 2025.
The swing from profit to loss in both Q4 and full-year FY25, accompanied by a YoY revenue decline, points to weakening operations and may weigh negatively on the stock in the short term. Shareholders should watch for management commentary on the reasons behind the loss and any demand or pricing headwinds going forward.